Pillar two

Therapeutics

The learning direction flipped: not “what do I know about this drug?” but “how do I treat this problem?”: goals, patient factors, class selection, escalation, and monitoring, with vignettes that change one variable and ask whether your answer survives.

Cardiovascular

Hypertension

Lower long-term cardiovascular and renal risk, not just today's number

5 classes · 1 vignette

Heart failure with reduced ejection fraction

Survival and hospitalization reduction with the four foundational pillars

5 classes · 1 vignette

Anticoagulation in atrial fibrillation

Prevent stroke in patients whose risk justifies anticoagulation

1 classes · 1 vignette

Endocrine

Type 2 diabetes

Individualized HbA1c target: tight where safe, relaxed where hypoglycemia bites hardest

1 classes · 1 vignette

Psychiatry

Major depressive disorder

Remission, not response, and function, not just scores

2 classes · 1 vignette

Gastrointestinal

GERD and acid-related disorders

Symptom control with the least acid suppression that achieves it

1 classes · 1 vignette

More therapeutic areas open as reviewer-approved content lands. The architecture already holds their shelves.